CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.
Check out our portfolio of awards below. Click here to see a list of People We’ve Funded. Click here to see a list of our Funded Institutions.
All CIRM Grants
Search Filters »
| Institution |
Researcher name |
Grant Type |
Grant Title |
Award Value |
| Gladstone Institutes, J. David |
Lyandysha (Lana) Viktorovna Zholudeva |
Quest – Discovery Stage Research Projects |
Excitatory spinal interneurons from human pluripotent stem cells to treat spinal cord injury |
$2,942,198 |
| University of California, Los Angeles |
Prof. Song Li |
Quest – Discovery Stage Research Projects |
Vax-CT to promote formation of cancer-specific T memory stem cell for personalized cancer immunotherapy |
$2,267,714 |
| University of California, Los Angeles |
Dr. Richard Joseph Pietras |
Quest – Discovery Stage Research Projects |
Reversal of dysregulated myelopoiesis in breast cancers and cancer stem cells to boost antitumor immunotherapy |
$2,327,680 |
| Greenstone Biosciences, Inc. |
Paul D Pang |
Quest – Discovery Stage Research Projects |
Drug Discovery for Duchenne Muscular Dystrophy Using Patient-Derived Human iPSCs |
$675,000 |
| University of California, Berkeley |
Mr. Fyodor Urnov |
Quest – Discovery Stage Research Projects |
A Treatment for Artemis-deficient Severe Combined Immunodeficiency using Non-Viral CRISPR-driven Safe Harbor Transgenesis in Hematopoietic Stem Cells |
$1,809,372 |
| University of California, Davis |
Aijun Wang PhD |
Quest – Discovery Stage Research Projects |
In Utero Treatment of Duchenne Muscular Dystrophy with Non-viral Gene Editing |
$2,035,544 |
| Rubedo Life Sciences Inc. |
Marco Quarta |
Quest – Discovery Stage Research Projects |
Pharmacological regenerative treatment of idiopathic pulmonary fibrosis targeting the senescent niche of lung progenitor cells. |
$1,450,876 |
| University of California, Los Angeles |
Dr. Gerald Lipshutz |
Quest – Discovery Stage Research Projects |
Gene Therapy for SLC6A8 Creatine Transporter Disorder |
$2,296,920 |
| University of California, Los Angeles |
Frank Pajonk |
Quest – Discovery Stage Research Projects |
Development of novel small molecules against cancer stem cells in solid cancers |
$2,340,000 |
| Lundquist Institute for Biomedical Innovation at Harbor – UCLA Medical Center |
Dr. Michelina Iacovino PhD |
Quest – Discovery Stage Research Projects |
A Novel Therapy for Sanfilippo B |
$2,297,884 |
| Cedars-Sinai Medical Center |
Dmitriy Sheyn |
Quest – Discovery Stage Research Projects |
Microgel encapsulated iPSC-derived notochordal cells to treat intervertebral disc degeneration and low back pain |
$2,020,166 |
| Scripps Health |
Dr. Darryl D. D’Lima |
Quest – Discovery Stage Research Projects |
Pluripotent Stem Cells for Tendon Tissue Engineering |
$2,734,163 |
| BrainXell Therapeutics |
Matthew Goodus |
Quest – Discovery Stage Research Projects |
Autologous stem cell-derived interneuron cell therapy for spinal cord injury (SCI) |
$2,025,000 |
| University of California, Berkeley |
Kevin E. Healy |
Quest – Discovery Stage Research Projects |
Novel Lipid Nanoparticles for Enhancing eNOS Synthesis for Cardioprotection Post Myocardial Infarction |
$2,060,248 |
| The Scintillon Institute |
Brian Lawson |
Quest – Discovery Stage Research Projects |
An hematopoietic stem-cell-based approach to treat HIV employing CAR T cells and anti-HIV broadly neutralizing antibodies. |
$1,143,600 |
| Nanotools Bioscience |
Dr. Alex Savtchenko PhD |
Quest – Discovery Stage Research Projects |
Enabling non-genetic activity-driven maturation of iPSC-derived neurons |
$675,000 |
| University of California, San Diego |
Dr. Joseph G. Gleeson |
Quest – Discovery Stage Research Projects |
Novel antisense therapy to treat genetic forms of neurodevelopmental disease. |
$1,180,654 |
| University of California, Davis |
Dr. Kyle D Fink PhD |
Quest – Discovery Stage Research Projects |
AAV-dCas9 Epigenetic Editing for CDKL5 Deficiency Disorder |
$1,413,054 |
| CellFE Biotech |
Sewoon Han |
Tool Translational Research Projects |
Purpose built cell engineering for rapid manufacturing of stem-like cell therapies |
$934,750 |
| Defined Bioscience, Inc. |
Steven Douglas Rees |
Tool Translational Research Projects |
Development of a low-cost, clinical-grade iPS maintenance medium for enabling stem cell therapy manufacturing |
$999,848 |
| Stanford University |
Professor Irving L Weissman MD |
Tool Translational Research Projects |
Purification of Human Hematopoietic Stem Cells (HSCs) for Clinical Stem Cell Transplantation |
$1,347,722 |
| HEALIOS NA, Inc. |
Dr. Norihiro Tsuneyoshi |
Tool Translational Research Projects |
Generation of human universal donor iPS cells |
$999,989 |
| University of California, Davis |
Dr Jan A Nolta |
Tool Translational Research Projects |
T-Pure: Peripheral Blood Processing Tool for Point of Care CAR-T Manufacturing |
$1,217,954 |
| Greenstone Biosciences, Inc. |
Paul D Pang |
Tool Translational Research Projects |
Cell Villages and Clinical Trial in a Dish with Pooled iPSC-CMs for Drug Discovery |
$1,350,000 |
| Organos, Inc. |
Samuel Wall |
Tool Translational Research Projects |
Human iPSC-derived micro-heart muscles for high-throughput cardiac drug discovery |
$1,119,382 |
| University of California, Davis |
Aijun Wang PhD |
Medical Device Translational Research Projects |
Living Synthetic Vascular Grafts with Renewable Endothelium |
$3,082,579 |
| Cedars-Sinai Medical Center |
Yuan Yuan |
Diagnostic Translational Research Projects |
A Rapid Clinical Digital Patient-derived Organoid to Guide Breast Cancer Treatment Decision |
$1,535,375 |
| University of California, Irvine |
Dr. Michael Demetriou |
Therapeutic Translational Research Projects |
GlyTR2 CAR T cell translation: safe pan-cancer killing via velcro-like density-dependent targeting of cancer glycans |
$4,581,144 |
| University of California, San Francisco |
Gregory Maness Allen |
Therapeutic Translational Research Projects |
FM-IL2 CAR T cells for Pancreatic Cancer |
$5,644,776 |
| Entos Pharmaceuticals |
John Lewis |
Therapeutic Translational Research Projects |
Lep001 – gene therapy for the treatment of congenital lipodystrophy |
$4,000,000 |
| Fate Therapeutics, Inc. |
Martin Hosking |
Therapeutic Translational Research Projects |
Development of an off-the-shelf iPSC derived CAR T cell therapy for the treatment of solid tumors |
$4,000,000 |
| Navega Therapeutics |
Ana Maria Moreno |
Therapeutic Translational Research Projects |
Development of an AAV Epigenetic Gene Therapy for Gain-of-Function SCN9A Disorders and Chronic Pain |
$3,982,633 |
| University of California, Los Angeles |
Roger Hollis |
Therapeutic Translational Research Projects |
Evaluation of an ex vivo lentiviral gene therapy for the treatment of Angelman syndrome |
$5,276,765 |
| ReviR Therapeutics |
Dr Paul R August |
Therapeutic Translational Research Projects |
Genetic Therapy Targeting mHTT mRNA and Somatic Expansion to Treat Huntington’s Disease |
$4,618,687 |
| University of Southern California |
David D. Tran |
Therapeutic Translational Research Projects |
A Novel Gene Therapy to Target Glioblastoma via Custom-Engineered Adenovirus-Associated Viral Vectors |
$5,927,454 |
| NysnoBio GT Neurology |
Jennifer Johnston |
Therapeutic Translational Research Projects |
Parkin Gene Therapy for Parkinson’s Disease |
$2,450,510 |
| Maro Bio |
Akanksha Chhabra |
Therapeutic Translational Research Projects |
A novel non-genotoxic antibody conditioning therapeutic to expand access to and safety of HSCT and CD34+ gene therapies |
$4,043,427 |
| Neurona Therapeutics |
Dr. Cory R Nicholas |
Therapeutic Translational Research Projects |
Development of a universal allogeneic human interneuron cell therapy candidate for the treatment of drug resistant focal epilepsy. |
$3,828,714 |
| University of California, Los Angeles |
Dr. Donald B. Kohn |
Therapeutic Translational Research Projects |
Hematopoietic Stem Cell Gene Therapy for Alpha Thalassemia |
$5,028,351 |
| Stanford University |
Natalia Gomez-Ospina |
Therapeutic Translational Research Projects |
Toward a Cure for Gaucher Disease Type 1: Autologous Transplantation of Genome Edited Hematopoietic Stem Cells |
$4,696,296 |
| University of California, Los Angeles |
Dr. Lili Yang |
Therapeutic Translational Research Projects |
Combating Ovarian Cancer with Stem Cell-Engineered Off-The-Shelf CAR-NKT Cell Therapy |
$5,601,600 |
| Axent Biosciences Inc. |
Rocio Sampayo |
Therapeutic Translational Research Projects |
A high quality, accessible cell therapy for Parkinson’s Disease produced in a scalable bioreactor system for 3D cell expansion and differentiation |
$3,999,241 |
| AcuraStem Incorporated |
Mr. Samuel V. Alworth MS, MBA |
Therapeutic Translational Research Projects |
Development of AS-241, an UNC13A Targeting Antisense Oligonucleotide (ASO) Treatment for ALS, for IND-enabling Studies |
$4,012,325 |
| Ray Therapeutics, INC |
Paul Bresge |
Therapeutic Translational Research Projects |
Optogenetic Therapy for Treatment of Geographic Atrophy |
$3,998,930 |
| University of California, Los Angeles |
Dr. Gerald Lipshutz |
Therapeutic Translational Research Projects |
Development of a Gene Therapy for Treatment of Guanidinoacetate Methyltransferase Deficiency-Translating In Vivo Proof of Concept to Support a Pre-IND |
$5,145,825 |
| University of California, San Francisco |
Sarah Monica Knox |
Therapeutic Translational Research Projects |
Neurogenic hydrogel stimulation of stem cells to regenerate radiation-damaged salivary glands |
$2,312,021 |
| Cedars-Sinai Medical Center |
Dr. Ahmed Gamal Ibrahim |
Therapeutic Translational Research Projects |
Noncoding RNA drug TY1 as a therapeutic candidate for scleroderma and systemic sclerosis |
$2,590,224 |
| University of California, Los Angeles |
Zulema Romero Garcia |
Therapeutic Translational Research Projects |
Adenine Base Editing for Autologous Hematopoietic Stem Cell Gene Therapy of CD3δ SCID |
$5,966,928 |
| University of California, San Diego |
Dr Karen Christman |
Therapeutic Translational Research Projects |
Pro-regenerative infusible ECM biomaterial for treating acute myocardial infarction |
$4,353,438 |
| University of California, Los Angeles |
Dr. Gerald Lipshutz |
Therapeutic Translational Research Projects |
Development of a Gene Therapy for the Treatment of Arginase Deficiency – Translating from Proof of Concept to Support Pre-IND Meeting |
$5,266,504 |
